|
Adrenal
adenomatoid
tumor, 313
adrenal pseudocyst, 35
CT guided radiofrequency ablation in tumors, 250
massive retroperitoneal hemorrhage, 35
percutaneous biopsy of masses, 160
rupture of pseudocyst, 35
Benign
prostatic hyperplasia
detrusor
instability, 136
international prostate symptom score, 135
irritative and obstructive symptoms, 137
lower urinary tract symptoms, 135
prostatism, 135
quality of life, 135
urodynamics, 135
Bladder
alleles
genotyping in bladder cancer, 280
arylamine N-Acetyltransferase and bladder cancer, 279
bladder cancer and androgen receptor, 526
bladder cancer in north India, 279
bladder instillations of resinferatoxin, 53
bladder neoplasms, 37, 83, 185, 192, 279, 296, 400, 406
bladder outlet obstruction, 135
bladder replacement with de-epithelialized ileum, 237
chemotherapy for bladder lymphoma, 38
cystectomy following radical prostatectomy, 125
cystoprostatectomies, incidence of prostatic and urothelial ca,
169
cystoprostatectomy for bladder cancer, coexistence of prostate ca,
296
device for vesicourethral anastomosis, 323
diagram of hematuria investigation, 189
extended lymphadenectomy in bladder cancer, 262
fast and slow acetylators and bladder cancer, 281
gabapentin for overactive bladder and nocturia, 275
ileal bladder in dogs, 237
infiltrating bladder cancer in elderly, 83
interstitial cystitis and nitric oxide, 81
interstitial cystitis and nitric oxide, 81
interstitial pneumonitis secondary to intravesical BCG, 400
IVU and bladder carcinoma, 185
laparoscopic partial cystectomy in cancer, 192
lymphadenectomy with cystectomy, 440
metastasectomy in urothelial cancer, 171
muscle invasion, diagnosis, 99
NAT2 polymorphism in bladder cancer, 279
neobladder in dogs, experimental, 237
neoplasm invasiveness, 296
non-Hodgkin lymphoma, 499
orthotopic neobladder, 125
orthotopic neobladder and previous prostatic surgery, 125
partial cystectomy, laparoscopic, 192
polymorphism genetics and bladder cancer, 279
postoperative instillations of chemotherapy for stage Ta T1, 353
primary lymphoma, 37
primary T1G3 bladder cancer, 530
resinferatoxin for bladder instability, 53
risk of bladder cancer, 279
tobacco and bladder cancer, 279
toxins instillations, 53
transabdominal ultrasound and bladder tumors, 185
simultaneous TUR of bladder tumor and BPH, 84
solitary fibrous tumor in bladder wall, 406
vesical and prostatic neoplasia, 296
vesical metastasis of gastric carcinoma, 403
vesical silicone modeler, 240
voiding dysfunction following sling surgery, 302
Children
adrenergic
alpha-antagonists, 128
adryamicin-induced fetal hydronephrosis, experimental, 508
ambitions of adolescents born with exstrophy, 446
amniotic fluid, rats, 508
antenatal disorders, 40
complete primary repair of bladder exstrophy, 439
congenital anomalies, 40, 49
cryptorchidism, 49
cystourethrogram, 504
desmopressin for nocturnal bedwetting, 266
diagnosis of intrauterine urinary obstruction, 42
DMSA abnormality and vesicoureteral reflux, 357
enuresis, 128
fetal hydronephrosis, experimental, 508
fetal surgery, 40
fetoscopy, 40
Fowler-Stephens orchiopexy, 175
intrauterine diagnosis and surgery, 40
imaging in neurogenic bladder, 504
kidney neoplasms in children, 227
myelomeningocele, 40
nephrectomy in children, 227
non-neurogenic neurogenic bladder dysfunction, 128
neurogenic bladder, 504
paternity after adolescent varicocele repair, 533
prenatal intervention for urinary obstruction, 40
prenatally diagnosed renal tumors, 534
prune-belly syndrome, 175
renal cell carcinoma in childhood, 227
techniques of intrauterine intervention, 43
urinary tract infection in children, 88
urinary obstruction, intrauterine, 40
urodynamic in neurogenic bladder, 132
vaginal construction with sigmoid colon, 358o
vesicoureteral reflux, 87, 504
voiding cystourethrogram, 130, 161, 504
voiding dysfunction in children, 128, 504
young males with varicocele, 448
Endourology
and Laparoscopy
abdominal
laparoscopy, complications, 70
fluid absorption during ureterorenoscopy, 516
laparoscopic live donor nephrectomy, 69
laparoscopic retroperitoneal lymph node dissection, 249
laparoscopic transuterine fetal vesicostomy, 518
laparoscopic vs. open partial nephrectomy, 429
nephrolitotomy in patients with neurogenic bladder, 247
nephrostomy: large, small or tubeless after percutaneous surgery,
426
precaval right renal arteries, 72
shock wave lithotripsy in Peyronie’s disease, 199
transperitoneal vs. extraperitoneal laparoscopic prostatectomy,
519
tumor seeding in urological laparoscopy, 261
ureteroscope, dual active deflection in ureteropyeloscopy, 428
Erectile
dysfunction and Ejaculation
corpus
cavernosum relaxation in trained rats, 258
following radical prostatectomy, 351
intracavernous injection of VEGF in aged rats, 437
Imaging
bone
scanning in staging prostate cancer, 341
coronal imaging to assess urinary tract stone size, 432
cortical renal thickness in obstruction, 105
cross-sectional area of renal parenchyma, 103
CT in juxtaglomerular cell tumor
CT in bladder carcinoma, 125
CT in pelvic Actynomicosis, 369
CT in residual mass post-chemotherapy for testis carcinoma, 384
CT in staging prostate cancer, 341
CT in renal cell carcinoma, 520
CT in renal cholesteatoma, 494
CT in renal papillary carcinoma, 520
differential creatinine clearance, 102
endoluminal ultrasound in urology, 96
IVU and bladder carcinoma, 185
IVU and neurogenic bladder in children, 129
neurogenic bladder in children, 504
non-contrast CT for creatinine clearance, 102
MRI and MR spectroscopic imaging after transrectal biopsy, 521
MRI in primary prostatic lymphoma, 411
MRI in renal cell carcinoma, 71
patient radiation dose at CT and conventional urography, 343
percutaneous biopsy of adrenal masses, 160
prostatic ultrasonography, 114
renal cortical thickness by ultrasound, 103
transabdominal ultrasound and bladder tumors, 185
ureteral cancer, 96
ultrasound and neurogenic bladder in children, 129
ultrasound in Peyronie’s disease, 201
unilateral chronically obstructed kidney, 102
voiding cystourethrogram in children, 130, 161
Impotence:
see Erectile dysfunction
Incontinence
cesarean
section and SUI, 174
laparoscopic Burch surgery, 230
longitudinal urethral sling for male incontinence, 307
male incontinence, 307
mechanical properties of urogynecologic implant materials, 531
Portuguese version of King’s Health Questionnaire, 479
pre and retropubic sling fixation for male, 307
prostheses and implants, 123, 302, 307
pubovaginal sling, 123, 302
quality of life questionnaire, 479
reconstructive surgical procedures, 302
sling, 123, 302
stress urinary incontinence, 230, 302, 479
tension free vaginal tape, 123, 532
urinary sphincter, 307
vaginal erosion of sling, 123
voiding dysfunction following sling surgery, 302
Infertility
cryopreservation
technique, 487
refreezing human spermatozoa, 487
intracytoplasmic sperm injection (ICSI), 487
liquid nitrogenic vapor, 487
Kidney
abnormalities,
319, 321
cake kidney drained by single ureter, 321
chemotherapy in kidney neoplasms, 210
cholesteatoma of upper tract, 494
cortical thickness by ultrasound, 103
creatinine clearance in chronically obstructed, 102
cyst, cholesteatoma, 494
differential renal function by CT, 102
dog kidney, 148
hematuria, renal origin, 216
high-energy shock waves, 142
horseshoe kidney and tumor, 319
hydronephrosis, 321
justaglomerular apparatus, 119
kidney neoplasms, 210, 214, 319
laparoscopic donor nephrectomy, 398, 416
partial nephrectomy, 216, 319
pyelic fusion and crossed single ureter, 319
rats, 142
renal cryoablation, 257
renal hemangioma, 216
renal parenchyma volume, 104
renal sarcoma, 210
shock waves effect on n-acetyl-beta-glucosaminidase, 142
unremitting hematuria after donor nephrectomy, 398
Kidney
cancer: see Renal neoplasms
Kidney
transplantation: see Renal transplantation
Lithiasis
anticonvulsants
and, 29
brushite stones, 156
calcium oxalate morphology, 205
crystallization, 205
diet, 29
effect of urinary calcium and oxalate on saturation, 515
high-energy shock waves effects, 142, 148
kidney, 32, 68
laparoscopic guided percutaneous nephrolithotripsy, 32
lithotripsy, experimental, 148
metabolism, 29
n-acetyl-beta-glucosaminidase and shock waves, 148
nephrectomy, 316
nephrocutaneous fistula, 316
nephrolithiasis in obese patients, 338
nifedipine versus tamsulosin for lower ureteral stones, 337, 339
pelvic kidney, 32
pH and body weight in lithiasis, 246
porcine model of calcium oxalate stone, 80
shock wave lithotripsy effects in liver, 142
shock wave lithotripsy effects in spleen, 142
shock wave lithotripsy in canine kidney, 148
stone comminution in SWL, 427
supersaturation, 205
topiramate associated, 29
transperitoneal nephrolithotripsy, 32
ureter, 67
urine supersaturation and calcium oxalate morphology, 205
|
Pathology
bladder
papilloma, 76
combined percentage of Gleason 4 and 5, 165
fat invasion in prostate needle biopsy, 346
high-grade PIN, 77
insignificant clinical T1c prostate tumors, 525
minute adenocarcinomas of prostate, 524
pelvic Actynomicosis, 369
prostate carcinoma, T1c versus T2, 255
pT2b prostate cancer, 256
renal cholesteatoma, 495
sarcomatoid renal cell carcinoma, 347
vascular invasion in prostate cancer, 164
vesical metastasis of gastric carcinoma, 404
Pelvis
infection,
367
pelvic Actinomycosis, 367
tumor, 367
Penis
alpha-agonist
for priapism, 121
gene profile, Peyronie vs. Dupuytren’s disease, 349
metamirol self-injection for priapism, 121
non-invasive treatment of Peyronie’s disease, 199
Peyronie’s disease, 199
priapism, 121
SWL for treatment of Peyronie’s disease, 199
sick cell and priapism, 121
vitamin E for Peyronie’s disease, 199
Prostate
and
overactive bladder, 275
digital rectal examination, 466
interobserver variation of prostatic volume, 466
laparoscopic extraperitoneal prostatectomy, 221
peri-prostatic anesthesia for biopsy, 114
primary lymphoma of the prostate, 410
prostatic volume estimation, 466
ultrasound guided biopsy
Prostate
cancer
advanced
disease, 461
androgen blockade, 3
anesthesia in biopsy, local, 380
antiandrogens, 3
biochemical failure after external radiotherapy, 289, 443
biopsy, 380, 436
bladder and prostatic neoplasia, 296
bladder neck invasion and PSA recurrence, 434
castration plus antiandrogen, 3
clinical stage and PSA velocity, 14
complete androgen blockage, 5
DHEA, 3
diagnosis, 109
digital rectal examination, 109
epidemiology, 3
expectant management after biochemical failure, 289
external radiotherapy, 289
follow-up of biochemical failure without immediate treatment, 289
flutamide, 3
free-to-total PSA ratio, 109
Gleason score, 15, 472
Gleason score and PSA velocity, 15
hormonal treatment for localized, 3, 455
hormone refractory, 3, 455
hormones, 289, 455
initial PSA and subsequent cancer detection, 442
intraoperative cell salvage during radical prostatectomy, 377
laparoscopic radical prostatectomy, 221
locally advanced disease, 455
localized prostate cancer, 12
LH-RH receptor, 3, 455
metastatic disease, 8, 455
needle biopsy, 109, 114, 380, 436
neoplasm metastasis, 455
neoplasms staging, 12
normal digital rectal examination, 109
patient age and PSA velocity, 14
percentage of fragments affected in biopsies, 472
periprostatic anesthesia in biopsy, 114
pathology, 12
post-brachytherapy RTUP in localized cancer, 441
prognosis, 3
prostatic cell, 6
prostatic neoplasms, 296, 410, 455, 472
prostatic-specific antigen (PSA), 12, 109, 289, 472
PSA increase following radiotherapy, 289
PSA velocity, normal examination, 109
PSA velocity, predictive value, 12
quality of life considerations, 455
radical prostatectomy in Jehovah’s witnesses, 377
radical retropubic prostatectomy, 12
risk factors of seminal vesicle involvement, 472
screening for, 3
testosterone, 3
three methods of anesthesia for transrectal biopsy, 430
transperineal biopsy, 6 versus 12 cores, 172
transrectal biopsy and lidocaine gel anesthesia, 380
tumor volume and PSA velocity, 14
ultrasound guided biopsy, 114, 380
Renal
neoplasms
clear
cell carcinoma in horseshoe kidney, 319
dendritic cell immunotherapy for urological cancers, 527
justaglomerular cell tumor, 119
pre-transplantation evaluation and, 214
renal sarcoma, 210
renal lipossarcoma, 214
sarcomatoid renal cell carcinoma, 347
Renal
transplantation
complications,
18, 22
evolution of creatinine in recipients of laparoscopic donor nephrectomy,
26
incidence of lymphocele, 18
laparoscopic live donor nephrectomy, 22, 398, 416
predisposing factors for lymphocele, 18
prevalence of lymphocele, 18
surgical technique for laparoscopic nephrectomy, 23
Surgical
technique
Acucise
endopyelotomy, 59
disposable instrument for vesicourethral anastomosis, 323
laparoscopic Burch surgery, 221
laparoscopic extraperitoneal prostatectomy, 221
laparoscopic partial cystectomy in cancer, 192
longitudinal urethral sling for male incontinence, 307
maximizing right renal vein length in donor nephrectomy, 416
minimally invasive procedures, 59
pre and retropubic sling fixation for male incontinence, 307
vesicourethral anastomosis, 323
Testis,
Adnexas and Scrotum
anatomy
of epididymis, 420
cryptorchidism, 49, 420
effect of peppermint tea on plasma testosterone and other hormones,
350
epididymis, 49, 420
germ cell tumor, 384, 389
laparoscopic retroperitoneal lymphadenectomy, 389
neoplasms, 384, 389
neoplasm metastasis, 384, 389
non-seminomatous testicular cancer, 384, 389
post-chemotherapy residual mass, 384
pseudotumor of the testis, 502
retroperitoneal lymph node dissection post-chemo, 384
schistossomal epididymitis, 413
testicular anatomy, 420
testis and cryptorchidism, 49
testicular appendages, 49, 420
testicular schistosomiasis, 502
testicular neoplasms, 384, 389
testicular torsion, 420
Tissue
engineering and reconstructive urology
bladder
replacement with de-epithelialized ileum, 237
fibrin glue for suture-less correction of chordee, 438
neuroanatomy of the male urethra, 259
orthotopic bladder substitution in women, 529
pregnancy and urinary tract reconstruction, 176
sexual behavior after hypospadia repair, 168
small intestinal submucosa as allograft, 327
TVT and fascia lata in rat model, 173
ureteral allograft in pigs with SIS, 327
urinary diversion, 125
urinary tract biomaterials, 260
urothelial cells culture, 82
vaginal and penile reconstruction, 528
Trauma
blunt
renal trauma, 162
bulbous urethral disruption, 252
high-grade renal injuries in children, 522
male external genitalia, 75
pediatric renal injuries, 434, 523
renal artery dissection, 74
renal injuries, consensus statement, 433
renal injury and operative management, 254
renal injury in children, 265
traumatic rupture of urinary bladder, 344
straddle injuries to bulbar urethra, 345
suprapubic catheter in acetabular fracture, 163
Ureter
arterioureteral
fistulas, 251
complications of ureteral stump, 398
endoluminal ultrasound for tumors, 99
evaluation of ureteral strictures, 99
extrinsic obstruction with indwelling stent, 340
forgotten ureteral stent, 159
nifedipine versus tamsulosin for lower ureteral stones, 337
ureteral access sheath, 157, 248
ureteral allograft with SIS in swine
ureteral cancer, 96
ureteral obstruction, 59, 102
ureteral healing after endopyelotomy, 78
ureteral endometriosis, 496
ureteral stricture, 59
Ureteropelvic
junction obstruction
Acucise
endopyelotomy, 59
durability of endourological intervention, 158
endoluminal ultrasound, 99
porcine model, 59
preoperative location of crossing vessels, 99
retrograde endopyelotomy, 59
surgical treatment, 59
Urethra
anterior
and posterior foreign bodies, 219
collagen injections, ultrasound guidance, 99
chronic urethral or pelvic pain in females, 354
device for vesicourethral anastomosis, 323
distal urethral polypropylene sling, 355
endoscopy, 219
foreign body, 219
longitudinal urethral sling for male incontinence, 307
NO synthase in urethral stricture, 166
pre and retropubic sling fixation for male incontinence, 307
urethral dysfunction in diabetic rats, 167
urethral diverticula, diagnosis, 99
urethral leiomyoma, 496
urethral hypermobility, 230
voiding dysfunction following sling surgery, 302
Voiding
dysfunction, see also incontinence
anticholinergic refractory, 53
anticholinergic refractory and gabapentin, 275
bladder instillations, 53
detrusor instability, 53, 136
diet and overactive bladder, 264
following aponeurotic sling surgery, 302
gabapentin for overactive bladder and nocturia, 275
longitudinal urethral sling for male incontinence, 307
male sling, 307
mixed incontinence and normal cystometrogram, 85
neuroanatomy of the lower urinary tract, 352
neuromodulation, 275
nocturia, 275
overactive bladder: percutaneous tibial nerve stimulation, 444
post-voiding residual urine, 302
pre and retropubic sling fixation for male incontinence, 307
resinferatoxin for detrusor instability, 53
sling for male incontinence, 307
sling surgery and bladder outlet obstruction, 445
SUI in bladder outlet obstruction, 263
toxins, bladder instillations, 53
urinary obstruction by prostatic lymphoma, 410
urination disorders, 275
urodynamics in detrusor instability, 53
|